Psychological therapies including dialectical behaviour therapy for borderline personality disorder: A systematic review and preliminary economic evaluation

Health Technology Assessment

Volumn 10, Issue 35, 2006, Pages 1-61

  Brazier, J ^a   Tumur, I ^a   Holmes, M ^a   Ferriter, M ^b   Parry, G ^a   Dent Brown, K ^a   Paisley, S ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b NOTTINGHAMSHIRE HEALTHCARE NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; METHADONE; METHYLPHENIDATE; MOOD STABILIZER; NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

BEHAVIOR THERAPY; BORDERLINE STATE; CHRONIC DISEASE; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; CLINICAL TRIAL; COGNITIVE THERAPY; COST EFFECTIVENESS ANALYSIS; DATA BASE; DRUG DEPENDENCE; ECONOMIC EVALUATION; EVIDENCE BASED MEDICINE; FOLLOW UP; GROUP THERAPY; HEALTH CARE DELIVERY; HEALTH CARE UTILIZATION; HOSPITALIZATION; HUMAN; INFORMATION PROCESSING; MEDICAL RESEARCH; META ANALYSIS; PSYCHOMETRY; PSYCHOPHARMACOTHERAPY; PSYCHOTHERAPY; QUALITY CONTROL; QUALITY OF LIFE; REVIEW; SUICIDE ATTEMPT; SYSTEMATIC REVIEW; TRANSFERENCE; VALIDATION PROCESS;

EID: 33750479805     PISSN: 13665278     EISSN: None     Source Type: Journal    
DOI: 10.3310/hta10350     Document Type: Review

References (116)

1. Tyrer P. Borderline personality disorder: a motley diagnosis in need of reform. Lancet 1999;354: 2095-6.
2. Weissman MM. The epidemiology of personality disorders: a 1990 update. J Pers Disord 1993;7(suppl 1):44-62.
3. Samuels J, Eaton WW, Bienvenu QJ III, Brown CH, Costa PT Jr, Nestadt G. Prevalence and correlates of personality disorders in a community sample. Br J Psychiatry 2002;180:536-42.
4. Torgersen S, Kringlen E, Cramer V. The prevalence of personality disorders in a community sample. Arch Gen Psychiatry 2001;58:590-6.
5. Coid J. Epidemiology, public health and the problem of personality disorder. Br J Psychiatry 2003;182:s3-10.
6. Swartz HA, Blaze DG, Winfield I. Estimating the prevalence of borderline personality disorder in the community. J Personal Disord 1990;4:457-572.
7. Widiger TA, Weissman MM. Epidemiology of borderline personality disorder. Hospital and Community Psychiatry 1991;42:1015-21.
8. Ogata SN, Silk NR, Goodrich S, Lohr N. Childhood sexual of physical abuse in adult patients with borderline personality disorder. Am J Psychiatry 1990;147:1008-13.
9. Shearer SL, Peters CP, Quaytman MS, Ogden RL. Frequency and correlates of childhood sexual and physical abuse histories and adult female borderline patients. Am J Psychiatry 1990; 147:214-6.
10. Paris J, Zweig-Frank H, Guzder H. Psychological risk factors for borderline personality disorder in female patients. Compr Psychiatry 1994;35:301-5.
11. Zanarini MC, Williams AA, Lewis RE, Reich RB. Reported pathological childhood experiences associated with the development of borderline personality disorder. Am J Psychiatry 1997;154:1101-6.
12. Livesley WJ, Jang KL, Vernon PA. Phenotypic and genetic structure of traits delineating personality disorder. Arch Gen Psychiatry 1998;55:941-8.
13. Skodol AE, Siever L, Livesley WJ, Gunderson J, Pfohl B, Widiger TA. The borderline diagnosis II: biology, genetics and clinical course. Biol Psychiatry 2002;51:951-63.
14. Carpenter W, Gunderson JP, Strauss J. Considerations of the borderline syndrome: a longitudinal comparative study of borderline and schizophrenic patients. In Borderline personality disorders: the concept, the syndrome, the patient. New York: International Universities Press; 1997. pp. 231-53.
15. Pope HG Jr, Jonas JM, Hudson JI, Cohen BM, Gunderson JG. The validity of DSM-III borderline personality disorder. A phenomenologic, family history, treatment response, and long-term follow-up study. Arch Gen Psychiatry 1983;40:23-30.
16. Werble B. Second follow-up of borderline patients. Arch Gen Psychiatry 1970;23:3-7.
17. McGlashan TH. The Chestnut Lodge follow-up study. I. Follow-up methodology and study sample. Arch Gen Psychiatry 1984;41:573-85.
18. Paris J, Brown R, Nowlis D. Long term follow up of borderline patients in a general hospital. Compr Psychiatry 1987;28:530-5.
19. Stone MH. Long-term outcome in personality disorders [review]. Br J Psychiatry 1993;162:299-313.
20. Lenzenweger ME, Johnson MD, Willett JB. Individual growth curve analysis illuminates stability and change in personality disorder features: the longitudinal study of personality disorders. Arch Gen Psychiatry 2004;61:1015-24.
21. Zanarini MC, Frankenburg FR, Khera GS, Bleichmar J. Treatment histories of borderline inpatients. Compr Psychiatry 2001;42:144-50.
22. Huffman JC, Popkin MK, Stern TA. Psychiatric considerations in the patient receiving organ transplantation: a clinical case conference. Gen Hosp Psychiatry 2003;25:484-91.
23. McGlashan TH, Grilo CM, Sanislow CA, Ralevski E, Morey LC, Gunderson JG. Two-year prevalence and stability of individual DSM-IV criteria for schizotypal, borderline, avoidant and obsessive-compulsive personality disorders: toward a hybrid model of Axis II disorders. Am J Psychiatry 2005;162:883-9.
24. Lieb K, Zanarini MC, Schmahl C, Linehan MM, Bohus M. Borderline personality disorder. Lancet 2004;364:453-61.
25. Conklin CZ, Westen D. Borderline personality disorder in clinical practice. Am J Psychiatry 2005;162:867-75.
26. Clarkin JE, Foelsch PA, Levy KN, Hull JW, Delaney JC, Kernberg OF. The development of a psychodynamic treatment for patients with borderline personality disorder: a preliminary study of behavioral change. J Personal Disord 2001;15:487-95.
27. Bateman A, Fonaghy P. Psychotherapy for borderline personality disorder: Mentalization based treatment. Oxford: Oxford University Press; 2004.
28. Linehan MM. Cognitive-behavioral treatment of borderline personality disorder. New York: Guilford Press; 1993.
29. Young JE, Klosko JS, Weishaar ME. Schema therapy: a practitioner's guide. New York: Guilford Press; 2003.
30. Evans K, Tyrer J, Catalan U, Schmidt K, Davidson J, Dent P. Manual-assisted cognitive-behaviour therapy (MACT): a randomized controlled trial of a brief intervention with bibliotherapy in the treatment of recurrent deliberate self-harm. Psychol Med 1999;29:19-25.
31. Davidson K. Cognitive therapy for personality disorders: a guide for therapists. Oxford: Butterworth-Heinemann; 2000.
32. Ryle A. Cognitive analytic therapy and borderline personality disorder: the model and the method. Chichester: John Wiley; 1997.
33. Linehan MM, Turner RM. Cognitive-behavioral treatment of borderline personality disorder [review]. Journal of Family Violence 1996; 11:429-32.
34. Boyce P, Carter G, Penrose-Wall J, Wilhelm K, Goldney R. Summary Australian and New Zealand clinical practice guideline for the management of adult deliberate self-harm (2003). Australasian Psychiatry 2003;11:150-5.
35. Warren F, McGauley G, Norton K, Dolan B, Preedy-Fayers K, Pickering A. Review of treatments for severe personality disorder. London: Home Office; 2003.
36. Lees J, Manning N, Rawlings B. Therapeutic community effectiveness: a systematic international review of therapeutic community treatment for people with personality disorders and mentally disordered offenders. CRD Report 17. York: Centre for Reviews and Dissemination; 1999.
37. Cornah D, Stein K, Stevens A. The therapeutic community method of treatment for borderline personality disorder. Southampton: WIHRD; 1997.
38. Binks CA, Fenton M, McCarthy L, Lee T, Adams CE, Duggan C. Psychological therapies for people with borderline personality disorder. Cochrane Database Syst Rev 2006;CD005652.
39. Hawton K, Arensman E, Townsend E, Bremner S, Feldman E, Goldney R, et al. Deliberate self harm: systematic review of efficacy of psychosocial and pharmacological treatments in preventing repetition. BMJ 1998;317:441-7.
40. van der Sande R, Buskens E, Allart E, van der Graaf Y, van Engeland H. Psychosocial intervention following suicide attempt: a systematic review of treatment interventions. Acta Psychiatr Scand 1997;96:43-50.
41. Perry JC, Banon E, Ianni E. Effectiveness of psychotherapy for personality disorders. Am J Psychiatry 1999;156:1312-21.
42. Leichsenring F. The effectiveness of psychodynamic therapy. A review using criteria of evidence-based medicine. Z Psychosom Med Psychother 2002;48:139-62.
43. Sanislow CA, McGlashan TH. Treatment outcome of personality disorders. Can J Psychiatry 1998;43:237-50.
44. Woods P, Richards D. Effectiveness of nursing interventions in people with personality disorders. J Adv Nurs 2003;44:154-72.
45. Bateman AW, Fonagy P. Effectiveness of psychotherapeutic treatment of personality disorder [review]. Br J Psychiatry 2000;177:138-43.
46. Clarke M, Oxman AD. The Cochrane reviewers handbook 4.1.4 [updated April 2002]. In The Cochrane Library. Oxford: Update Software; 2002.
47. Oxman AD, Cook DJ, Guyatt GH. Evidence Based Medicine Working Group. Users' guides to the medical literature VI. How to use an overview. JAMA 1994;272:1367-71.
48. Guyatt GH, Sackett DL, Cook DJ. Users' guides to the medical literature II. How to use an article about therapy or prevention. A. Are the results of the study valid? JAMA 1993,270:2598-601.
49. Guyatt GH, Sackett DL, Cook DJ. Users' guides to the medical literature II. How to use an article about therapy or prevention. B. What were the results and will they help me in caring for my patients? JAMA 1994;271:59-63.
50. Drummond M, Jefferson TO. Guidelines for authors and peer reviewers of economic submissions to the BMJ. BMJ 1996;313:275-83.
51. Bateman A, Fonagy P. Effectiveness of partial hospitalization in the treatment of borderline personality disorder: a randomized controlled trial. Am J Psychiatry 1999; 156:1563-9.
52. Koons CR, Robins CJ, Tweed JL, Lynch TR, Gonzalez AM, Morse JQ et al. Efficacy of dialectical behavior therapy in women veterans with borderline personality disorder. Behavior Therapy 2001;32:371-90.
53. Linehan MM, Armstrong HE, Suarez A, Allmon D, Heard HL. Cognitive-behavioral treatment of chronically parasuicidal borderline patients. Arch Gen Psychiatry 1991;48:1060-4.
54. Linehan MM, Schmidt H III, Dimelf LA, Craft JC, Kanter J, Comtois KA. Dialectical behavior therapy for patients with borderline personality disorder and drug-dependence. Am J Addict 1999;8:279-92.
55. Linehan MM, Dimeff LA, Reynolds SK, Comtois KA, Welch SS, Heagerty P, et al. Dialectical behavior therapy versus comprehensive validation therapy plus 12-step for the treatment of opioid dependent women meeting criteria for borderline personality disorder. Drug Alcohol Depend 2002;67:13-26.
56. Munroe-Blum H, Marziali E. A controlled trial of short-term group treatment for borderline personality disorder. J Personal Disord 1995;9:190-8.
57. Turner RM. Naturalistic evaluation of dialectical behavior therapy-oriented treatment for borderline personality disorder. Cognitive and Behavioral Practice 2000;7:413-9.
58. Tyrer P, Thompson S, Schmidt U, Jones V, Knapp M, Davidson K, et al. Randomized controlled trial of brief cognitive behaviour therapy versus treatment as usual in recurrent deliberate self-harm: the POPMACT study. Psychol Med 2003;33:969-76.
59. van den Bosch LM, Verheul R, Schippers GM, van den Brink W. Dialectical behavior therapy of borderline patients with and without substance use problems. Implementation and long-term effects. Addict Behav 2002;27:911-23.
60. Wilberg T, Friis S, Karterud S, Mehlum L, Urnes O, Vaglum P. Outpatient group psychotherapy: a valuable continuation treatment for patients with borderline personality disorder treated in a day hospital? A 3-year follow-up study. Nord J Psychiatry 1998;52:213-2 1.
61. Linehan MM, Heard HL, Armstrong HE. Naturalistic follow-up of a behavioral treatment for chronically parasuicidal borderline patients. Arch Gen Psychiatry 1993;50:971-4.
62. Bateman A, Fonagy R Treatment of borderline personality disorder with psychoanalytically oriented partial hospitalization: an 18-month follow-up. Am J Psychiatry 2001;158:36-42.
63. Tyrer P, Tom B, Byford S, Schmidt U, Jones V, Davidson K, et al., POPMACT Group. Differential effects of manual assisted cognitive behavior therapy in the treatment of recurrent deliberate self-harm and personality disturbance: the POPMACT study. J Personal Disord 2004;18:102-16.
64. Verheul R, van den Bosch LM, Koeter MW, De Ridder MA, Stijnen T, van den Brink W Dialectical behaviour therapy for women with borderline personality disorder: 12-month, randomised clinical trial in The Netherlands. Br J Psychiatry 2003;182:135-40.
65. Lackner JM, Mesmer C, Morley S. Psychological treatments for irritable bowel syndrome: a systematic review and meta analysis. J Consult Clin Psychol 2004;72:1100-13.
66. Hollis S, Campbell F. What is meant by intention-to-treat analysis? Survey published randomised controlled trials. BMJ 1999;319:670-4.
67. Linehan MM, Kanter JW, Comtois KA. Dialectical behavior therapy for borderline personality disorder. In Janowsky D (editor), Psychotherapy indications and outcomes. Washington, DC: American Psychiatric; 1993. pp. 93-118.
68. Heard HL. Cost-effectiveness of dialectical behavior therapy for borderline personality disorder. Dissertation Abstracts International Section B: Sciences and Engineering 2000;61(6B):3278.
69. Byford S, Knapp M, Greenshields J, Ukoumunne OC, Jones V, Thompson S, et al. Cost-effectiveness of brief cognitive behaviour therapy versus treatment as usual in recurrent deliberate self-harm: a decision-making approach. Psychol Med 2003;33:977-86.
70. Bateman A, Fonagy R. Health service utilization costs for borderline personality disorder patients treated with psychoanalytically oriented partial hospitalization versus general psychiatric care. Am J Psychiatry 2003; 160:169-71.
71. Hall J, Caleo S, Stevenson J, Meares R. An economic analysis of psychotherapy for borderline personality disorder patients. J Ment Health Policy Econ 2001;4:3-8.
72. National Institute for Clinical Excellence. NICE Guide to the Methods of Technology Appraisal. London: NICE; 2004.
73. Kaltenthaler E, Brazier J, De Nigris E, Tumur I, Ferriter M, Beverley C, et al. Computerised cognitive behaviour therapy for depression and anxiety update: a systematic review and economic evaluation. Health Technol Assess 2006;10(33).
74. Office for National Statistical. Hospital and community health services pay and prices index. London: ONS; 2005.
75. Rees A, Barkham M. DBT practice research network: DBT treatment implementation survey: feedback to practitioners. PTRC Memo No. 495. Leeds: Psychological Therapies Research Centre, University of Leeds; 2001.
76. Palmer R. Dialectical behaviour therapy for borderline personality disorder. Advances in Psychiatric Treatment 2002;8:16.
77. Curtis L, Netten A, Unit costs of health and social care. Canterbury: PRSSU, University of Kent; 2003.
78. Turner RM, Understanding dialectical behavior therapy. Clinical Psychology: Science and Practice 2000;7:95-8.
79. Gabbard GO, Lazar SG, Hornberger J, Spiegel D. The economic impact of psychotherapy: a review. Am J Psychiatry 1997;154:147-55.
80. Heard HL. Cost-effectiveness of dialectical behavior therapy in the treatment of borderline personality disorder. Dissertation Abstracts International: Section B: The Sciences and Engineering 2000;61:3278-358.
81. Allard R, Marshall M, Plante MC. Intensive follow-up does not decrease the risk of repeat suicide attempts. Suicide Life Threat Behav 1992;22:303-14.
82. Chiesa M, Fonagy P, Holmes J, Drahorad C. Residential versus community treatment of personality disorders: a comparative study of three treatment programs. Am J Psychiatry 2004;161:1463-70.
83. Clarkin JF, Levy KN, Lenzenweger ME, Kernberg OF. The Personality Disorders Institute/Borderline Personality Disorder Research Foundation randomized control trial for borderline personality disorder: rationale, methods, and patient characteristics. J Personal Disord 2004;18:52-72.
84. Manning SY. The effects of a cognitive-behavioral treatment on females with borderline personality disorder. Dissertation Abstracts International Section A: Humanities and Social Sciences 1997;57:2880.
85. Piper WE, Rosie JS, Azim HF, Joyce AS. A randomized trial of psychiatric day treatment for patients with affective and personality disorders. Hospital and Community Psychiatry 1993;44: 757-63.
86. Simpson EB, Yen S, Costello E, Rosen K, Begin A, Pistorello J, et al. Combined dialectical behavior therapy and fluoxetine in the treatment of borderline personality disorder. J Clin Psychiatry 2004;65:379-85.
87. Sloane RB, Staples FR, Cristol AH, Yorkston NJ. Short-term analytically oriented psychotherapy versus behavior therapy. Am J Psychiatry 1975;132:373-7.
88. Springer T, Lohr NE, Buchtel HA, Silk KR. A preliminary report of short-term cognitive-behavioral group therapy for inpatients with personality disorders. Journal of Psychotherapy Practice and Research 1996;5:57-71.
89. Stiwne D. Group psychotherapy with borderline patients: contrasting remainers and dropouts. Group 1994;18:37-45.
90. Winston A, Laikin M, Pollack J, Sainstag LW, McCullough L, Muran JC. Short-term psychotherapy of personality disorders. Am J Psychiatry 1994;151:190-4.
91. Bohus M, Haaf B, Stiglmayr C, Pohl U, Bohme R, Linehan M. Evaluation of inpatient dialectical-behavioral therapy for borderline personality disorder - a prospective study. Behav Res Ther 2000;38:875-87.
92. Bohus M, Haaf B, Simms T, Limberger MF, Schmahl C, Unckel C, et al. Effectiveness of inpatient dialectical behavioral therapy for borderline personality disorder: a controlled trial. Behav Res Ther 2004;42:487-99.
93. Brobyn S, Goren S, Lego S. The borderline patient: systemic versus psychoanalytic approach. Arch Psychiatr Nurs 1987; 1: 172-82.
94. Battegay R, Klaui C. Analytically oriented group psychotherapy with borderline patients as long-term crisis management. Crisis: Journal of Crisis Intervention and Suicide 1986;7:94-110.
95. Buzov I, Persic-Brida M. Rascjepljivanje i projektivna identifikacija u kratkoj dinamskoj psihoterapiji granicnog poremecaja licnosti [Splitting and projective identification in short dynamic psychotherapy of patients with a borderline personality disorder]. Socijalna Psihijatrija 1985;13:21-30.
96. Chiesa M, Drahorad C, Longo S. Early termination of treatment in personality disorder treated in a psychotherapy hospital: quantitative and qualitative study. Br J Psychiatry 2000; 177:107-11.
97. Clarkin JF, Marziali E, Munroe-Blum H. Group and family treatments for borderline personality disorder. Hospital and Community psychiatry 1991;42:1038-43.
98. Clarkin JE, Hull J, Yeomans F, Kakuma T, Cantor J. Antisocial traits as modifiers of treatment response in borderline inpatients. Journal of Psychotherapy Practice and Research 1994;3:307-12.
99. Damman G, Kachele H. Outcomes of psychodynamic treatment of borderline disorders. Nervenheilkunde 2001;20:31-7.
100. Dolan B, Warren F, Norton K. Change in borderline symptoms one year after therapeutic community treatment for severe personality disorder. Br J Psychiatry 1997;171:274-9.
101. Hirvas J. [Practical experience with psychoanalytic management of borderline personality disorder] [in Finnish]. Duodecim 1987;103:1387-90.
102. Karterud S, Kvarstein E, Pedersen G. Severely disturbed borderline patients need more than short-term day hospital treatment. Therapeutic Communities 2004;25:120-30.
103. Kent ML, Hartstone MD. Trial of a structured cognitive behaviour group therapy program for patients with borderline personality disorder. Aust N Z J Psychiatry 2000;34:A36.
104. Kern RS, Kuehnel TG, Teuber J, Hayden J L. Multimodal cognitive-behavior therapy for borderline personality disorder with self-injurious behavior. Psychiatr Serv 1997;48:1131-3.
105. Koenigsberg HW, A comparison of hospitalized and nonhospitalized borderline patients. Am J Psychiatry 1982;139:1292-7.
106. Lopez D, Cuevas P, Gomez A, Mendoza J. Transference-focused psychotherapy for borderline personality disorder. A study with 44 female patients. Salud Mental 2004;27:44-54.
107. Meares R, Stevenson J, Comerford A. Psychotherapy with borderline patients: I. A comparison between treated and untreated cohorts. Aust N Z J Psychiatry 1999;33:467-72.
108. Pfitzer F, Rosen E, Esch E, Held T. [Inpatient psychiatric treatment of borderline patients] [in German]. Nervenarzt 1990;61:294-300.
109. Rathus JH, Miller AL. Dialectical behavior therapy adapted for suicidal adolescents. Suicide Life Threat Behav 2002;32:146-57.
110. Ryle A, Golynkina K. Effectiveness of time-limited cognitive analytic therapy of borderline personality disorder: factors associated with outcome. British Journal of Medical Psychology 2000;73:197-210.
111. Schane M, Kovel V. Family therapy in severe borderline personality disorders. International Journal of Family Psychiatry 1988;9:241-58.
112. Ushijima S. Treatment of patients with borderline personality disorder with dynamic psychotherapy] [in Japanese]. Seishin Shinkeigaku Zasshi 1994;96:676-83.
113. Wildgoose A, Clarke S, Waller G. Treating personality fragmentation and dissociation in borderline personality disorder: a pilot study of the impact of cognitive analytic therapy. British Journal of Medical Pychology 2001; 74:47-55.
114. Carkhuff RR, Berenson BG. Teaching as treatment. Amherst, MA: Human Resources Development Press; 1976.
115. Richards A, Barkham B, Cahill J, Richards D, Williams C, Heywood P. PHASE: a randomised, controlled trial of supervised self-help cognitive-behavoural therapy in primary care. Br J Gen Pract 2003;53:764-70.
116. Brazier JE, Kolotkin RL, Crosby RD, Williams GR. Estimating a preference-based single index for the Impact of Weight on Quality of Life-Lite Instrument (IWQOL-Lite) from the SF-61). Value Health 2004;7:490-8.